We are live on ! Find out more
CPC

Cookson Peirce & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 94.11%
This Fund
S&P 500
This Quarter Est. Return
+10.82%
1 Year Est. Return
+94.11%
3 Year Est. Return
+306.52%
5 Year Est. Return
+526.41%
10 Year Est. Return
+3,285.24%
AUM
$1.54B
AUM Growth
+$120M
Cap. Flow
-$6.56M
Cap. Flow %
-0.43%
Top 10 Hldgs %
29.96%
Holding
232
New
47
Increased
111
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$31.9M
2
LW icon
Lamb Weston
LW
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$18.1M
4
GS icon
Goldman Sachs
GS
+$17.5M
5
FCNCA icon
First Citizens BancShares
FCNCA
+$16.3M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$31.8M
2
SNPS icon
Synopsys
SNPS
+$26.6M
3
KIM icon
Kimco Realty
KIM
+$23.1M
4
NI icon
NiSource
NI
+$21.1M
5
UNP icon
Union Pacific
UNP
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.76%
2 Technology 16.54%
3 Financials 14.35%
4 Industrials 13.12%
5 Consumer Staples 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
76
Apple
AAPL
$4.54T
$2.18M 0.14%
16,752
-6,037
-26% -$863K
SCHW
77
Charles Schwab
SCHW
$183B
$2.12M 0.14%
+25,495
New +$1.98M
VTV icon
78
Vanguard Morningstar Value ETF
VTV
$188B
$2.07M 0.13%
14,743
+379
+3% +$52.2K
TKR icon
79
Timken Company
TKR
$9.56B
$2.02M 0.13%
+28,571
New +$2M
NFLX icon
80
Netflix
NFLX
$299B
$1.8M 0.12%
60,910
-44,190
-42% -$1.24M
MGPI icon
81
MGP Ingredients
MGPI
$379M
$1.69M 0.11%
15,893
-1,700
-10% -$190K
FTNT icon
82
Fortinet
FTNT
$119B
$1.57M 0.1%
32,173
-15,989
-33% -$833K
FCX icon
83
Freeport-McMoran
FCX
$90B
$1.57M 0.1%
+41,286
New +$1.44M
PTC icon
84
PTC
PTC
$15.8B
$1.46M 0.09%
+12,126
New +$1.45M
FWONK icon
85
Liberty Media Series C
FWONK
$24.6B
$1.42M 0.09%
24,526
-10,347
-30% -$592K
AUR icon
86
Aurora
AUR
$12.6B
$1.41M 0.09%
1,164,272
-328,251
-22% -$560K
GD icon
87
General Dynamics
GD
$104B
$1.35M 0.09%
5,438
-625
-10% -$152K
UTHR icon
88
United Therapeutics
UTHR
$25.8B
$1.34M 0.09%
4,836
-360
-7% -$90.9K
NBIX icon
89
Neurocrine Biosciences
NBIX
$16.8B
$1.32M 0.09%
11,025
-379
-3% -$44.4K
TTC icon
90
Toro Company
TTC
$8.75B
$1.27M 0.08%
+11,262
New +$1.19M
IBM icon
91
IBM
IBM
$211B
$1.27M 0.08%
+9,046
New +$1.25M
ASML icon
92
ASML
ASML
$626B
$1.27M 0.08%
+2,323
New +$1.22M
RPV icon
93
Invesco S&P 500 Pure Value ETF
RPV
$1.65B
$1.21M 0.08%
15,538
+975
+7% +$76.1K
CVX icon
94
Chevron
CVX
$392B
$1.16M 0.08%
6,464
+262
+4% +$45.7K
MGM icon
95
MGM Resorts International
MGM
$11.4B
$1.15M 0.07%
+34,162
New +$1.18M
XOM icon
96
ExxonMobil
XOM
$644B
$1.14M 0.07%
10,333
+1,469
+17% +$157K
HAE icon
97
Haemonetics
HAE
$3.89B
$1.13M 0.07%
14,344
-998
-7% -$80.2K
EVR icon
98
Evercore
EVR
$12.4B
$1.13M 0.07%
+10,318
New +$1.08M
ABBV icon
99
AbbVie
ABBV
$443B
$1.12M 0.07%
6,916
-1,370
-17% -$210K
TCOM icon
100
Trip.com Group
TCOM
$29.6B
$1.09M 0.07%
+31,567
New +$907K
2 3
4
5 6

Similar funds

MB
MUFG Bank Tokyo 100-8388,, Japan $3.04B AUM 15.55% 1-Year Est. Return
MCM
MKP Capital Management New York $3.04B AUM 20.46% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
EP
Edgestream Partners Princeton, New Jersey $3.05B AUM 12.73% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return

Cookson Peirce & Co's Q4 2022 Portfolio in Review

As of Q4 2022, Cookson Peirce & Co held 232 positions worth $1.54B, up 8.4% from $1.42B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cookson Peirce & Co's Q4 2022 filing shows 47 new, 111 increased, 37 reduced and 30 closed positions. Its largest new stake was Lamb Weston: 283,180 shares worth $25.3M. The largest sale was AstraZeneca, an estimated $31.8M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

  • Cookson Peirce & Co's largest Q4 2022 buy was Lamb Weston: 283,180 shares worth $25.3M.
  • Cookson Peirce & Co added most to Merck in Q4 2022, an estimated $31.9M increase.
  • Cookson Peirce & Co's biggest Q4 2022 reduction was AstraZeneca, cutting an estimated $31.8M.
  • Cookson Peirce & Co fully exited Synopsys in Q4 2022, selling an estimated $26.6M.
  • Cookson Peirce & Co's ten largest holdings make up 30% of its $1.54B portfolio in Q4 2022.
  • Cookson Peirce & Co opened 47 new positions and closed 30 in Q4 2022.
  • Cookson Peirce & Co's portfolio value rose 8.4% quarter-over-quarter to $1.54B.

Based on Cookson Peirce & Co's 13F filing for Q4 2022, filed 31 Jan 2023.